In a tragic turn of events, a toddler named Dylan Findlay passed away while on a dream family vacation to Disneyland Paris. Dylan had contracted Covid-19 along with another common virus called respiratory syncytial virus (RSV). Shortly after arriving in France with his parents Alison and Robert and older brother Niall, Dylan’s condition worsened, eventually leading to his untimely death.
According to a post-mortem examination, Dylan had not shown any obvious symptoms despite testing positive for both viruses. This devastating loss has left his heartbroken parents questioning why their son was not given preventative treatment for RSV by doctors. They believe that such treatment may have made a difference in Dylan’s outcome. Mrs. Findlay expressed her grief, stating, “We’ll never know the difference that could have made to him.”
Dylan had previously been treated for a rare condition that affects one in every 5,000 children, but had been given clearance by doctors to go on the trip. Born prematurely and relying on a feeding tube, Dylan’s condition had stabilized over the past year. His parents had sought permission to bring him to Disneyland Paris as he loved playing with his older brother.
On the day they arrived, however, Dylan started vomiting, and his condition rapidly deteriorated. His parents immediately called for medical assistance, and despite their desperate efforts, Dylan lost consciousness and eventually passed away. The Findlay family has received overwhelming support from the community, with well-wishers donating toys worth over £2,000 to Aberdeen Royal Infirmary in memory of Dylan’s second birthday.
In addition to mourning their beloved son, the Findlay family is also questioning whether Dylan would have benefited from a preventative antibody treatment for RSV, which he had received the previous winter. Although there is no vaccine for RSV, high-risk children can be given the drug palivizumab through monthly injections. Unfortunately, Dylan did not meet the criteria to receive this treatment during the winter before his passing.
Alison Findlay expressed her concerns, stating, “Dylan contracted RSV last winter, and if he had not received the preventative drug, his condition could have been much worse.” She further added, “We believe things would have been different, but we cannot say for sure. He showed no signs of illness, so we were unaware.”
Mr. Findlay, who works at Aberdeen University, emphasized that Dylan’s passing had nothing to do with his pre-existing condition and was unrelated. He believes that this could have happened to any child, as Dylan contracted RSV and Covid-19, likely leading to his death according to the initial autopsy results.
The family now seeks to raise awareness about the importance of preventative treatments like palivizumab for high-risk children. NHS Grampian follows the guidelines set by the National Institute for Health and Care Excellence, which state that palivizumab should be prescribed under specialist supervision based on the likelihood of hospitalization. The Findlay family hopes that by sharing their story, they can bring attention to this issue and prevent other families from experiencing the same heartbreak.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
